UBS Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-193,555
Closed -$2.89M 10124
2022
Q4
$2.89M Buy
193,555
+191,896
+11,567% +$2.87M ﹤0.01% 2259
2022
Q3
$13K Sell
1,659
-502
-23% -$3.93K ﹤0.01% 7025
2022
Q2
$14K Sell
2,161
-3,293
-60% -$21.3K ﹤0.01% 6437
2022
Q1
$31K Sell
5,454
-1,226
-18% -$6.97K ﹤0.01% 5950
2021
Q4
$31K Buy
6,680
+6,480
+3,240% +$30.1K ﹤0.01% 6279
2021
Q3
$1K Hold
200
﹤0.01% 8287
2021
Q2
$1K Sell
200
-916
-82% -$4.58K ﹤0.01% 8210
2021
Q1
$9K Sell
1,116
-5,589
-83% -$45.1K ﹤0.01% 7030
2020
Q4
$39K Buy
6,705
+5,988
+835% +$34.8K ﹤0.01% 5415
2020
Q3
$4K Sell
717
-4,324
-86% -$24.1K ﹤0.01% 6607
2020
Q2
$26K Buy
5,041
+4,530
+886% +$23.4K ﹤0.01% 5549
2020
Q1
$2K Sell
511
-2,818
-85% -$11K ﹤0.01% 6781
2019
Q4
$21K Buy
3,329
+1,476
+80% +$9.31K ﹤0.01% 5800
2019
Q3
$16K Buy
1,853
+1,629
+727% +$14.1K ﹤0.01% 5934
2019
Q2
$1K Buy
224
+24
+12% +$107 ﹤0.01% 6912
2019
Q1
$2K Sell
200
-5,084
-96% -$50.8K ﹤0.01% 6658
2018
Q4
$84K Sell
5,284
-2,571
-33% -$40.9K ﹤0.01% 4806
2018
Q3
$260K Buy
7,855
+2,121
+37% +$70.2K ﹤0.01% 4051
2018
Q2
$129K Buy
5,734
+5,724
+57,240% +$129K ﹤0.01% 4396
2018
Q1
$0 Hold
10
﹤0.01% 7212
2017
Q4
$0 Sell
10
-1,558
-99% ﹤0.01% 7097
2017
Q3
$57K Buy
1,568
+1,558
+15,580% +$56.6K ﹤0.01% 4825
2017
Q2
$0 Sell
10
-112
-92% ﹤0.01% 7007
2017
Q1
$1K Buy
122
+99
+430% +$811 ﹤0.01% 6575
2016
Q4
$0 Sell
23
-19
-45% ﹤0.01% 7018
2016
Q3
$0 Sell
42
-961
-96% ﹤0.01% 6969
2016
Q2
$10K Buy
1,003
+943
+1,572% +$9.4K ﹤0.01% 5917
2016
Q1
$1K Sell
60
-1,158
-95% -$19.3K ﹤0.01% 6607
2015
Q4
$16K Sell
1,218
-489
-29% -$6.42K ﹤0.01% 5740
2015
Q3
$21K Buy
1,707
+894
+110% +$11K ﹤0.01% 5410
2015
Q2
$14K Buy
813
+484
+147% +$8.34K ﹤0.01% 5774
2015
Q1
$4K Sell
329
-2,873
-90% -$34.9K ﹤0.01% 6290
2014
Q4
$27K Buy
+3,202
New +$27K ﹤0.01% 5254